Skin Cancers Following Pediatric Organ Transplantation

Dermatologic Surgery

Volumn 30, Issue 4 II, 2004, Pages 616-621

  Euvrard, Sylvie ^a   Kanitakis, Jean ^a   Cochat, Pierre ^a   Claudy, Alain ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANUS CARCINOMA; BASAL CELL CARCINOMA; CANCER PREVENTION; CANCER RISK; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY GRAFT; LIVER GRAFT; MEDICAL LITERATURE; MELANOMA; PATIENT EDUCATION; PENIS CARCINOMA; PRIORITY JOURNAL; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; UTILIZATION REVIEW; VULVA CARCINOMA;

EID: 1942540105     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200404020-00008     Document Type: Review

References (33)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91.
2. Le Prélèvement et la Greffe en France en 1998. Rapport annuel. Paris: Etablissement français des Greffes; 1999.
3. Bucuvalas JC, Ryckman FC. Long-term outcome after liver transplantation in children. Pediatr Transplant 2002;6:30-6.
4. Penn I. De novo malignancy in pediatric organ transplant recipients. Pediatr Transplant 1998;2:56-63.
5. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001;44:932-9.
6. Kelly DA. Optimal immunosuppression in teenagers. Pediatr Transplant 2002;6:480-7.
7. Vanrenterghem YFC. Tailoring immunosuppressive therapy for renal transplant recipients. Pediatr Transplant 2001;5:467-72.
8. Harmon WE, Stablein DM, Sayegh MH. Trends in immunosuppressive strategies in pediatric kidney transplantation [abstract]. Am J Transplant 2003;3(Suppl 5):285.
9. Euvrard S, Ulrich C, Lefrançois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004;30(Suppl):626-631.
10. Coutinho HM, Groothoff JW, Offringa M, Gruppen MP, Heymans HS. De novo malignancy after paediatric renal replacement therapy. Arch Dis Child 2001;85:478-83.
11. Sindhi R. Sirolimus in pediatric transplant recipients. Transplant Proc 2003;35:S3A, 113-4.
12. Offner G, Latta K, Hoyer P, et al. Kidney transplanted children come of age. Kidney Int 1999;55:1509-17.
13. Gruber SA, Gillingham K, Sothern RB, et al. Cancer development in pediatric primary renal allograft recipients. Transplant Proc 1994;26:3-4.
14. Wingen AM, Wiesel M, Möhring K, Schärer K, Mehls O. Malignancies in children with renal replacement. Transplant Proc 1994;26:5-6.
15. Nocera A, Ghio L, Dall'Amico R, et al. De novo cancers in paediatric renal transplant recipients: a multicentre analysis within the North Italy Transplant programme, Italy. Eur J Cancer 2000;36:80-6.
16. Bernstein D, Baum D, Berry G, et al. Neoplastic disorders after pediatric heart transplantation. Circulation 1993;88:230-7.
17. Menni S, Beretta D, Piccino R, Ghio L. Cutaneous and oral lesions in 32 children after renal transplantation. Pediatr Dermatol 1991;8:194-8.
18. Halpert E, Tunnessen WW, Fivush B, Case B. Cutaneous lesions associated with cyclosporine therapy in pediatric renal transplant recipients. J Pediatr 1991;119:489-91.
19. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
20. Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for non-familial nodular and superficial spreading melanoma. Cancer 1990;66:387-95.
21. Barker JNW, MacDonald DM. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol 1988;13:123-5.
22. McGregor JM, Barker JNW, MacDonald DM. The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. Clin Exp Dermatol 1991;16:131-2.
23. Smith CH, McGregor JM, Barker JNW, et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993;28:51-5.
24. Naldi L, Adamoli L, Fraschini D, et al. Number and distribution of melanocytic naevi in individuals with a history of childhood leukaemia. Cancer 1996;77:1402-8.
25. Kanitakis J, Euvrard S, Faure M, Claudy A. Caractères prolifératifs des naevus chez les enfants greffés d'organe. Ann Dermatol Vénéréol 1999;126:687-90.
26. Bourguignon JP, Piérard E, Ernould C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet 1993;341:1505-6.
27. Fournet JC, Peuchmaur M, Eckart P, et al. Multicentric Kaposi's sarcoma in a 5-year-old human immunodeficiency virus-negative renal allograft recipient. Hum Pathol 1992;23:956-60.
28. Al-Sulaiman MH, Mousa DH, Rassoul Z, et al. Transplant-related Kaposi sarcoma in children. Nephrol Dial Transplant 1994;9:443-5.
29. Drut R, Drut RM. EBV-associated Kaposi's sarcoma in a pediatric renal transplant recipient. Pediatr Pathol 1994;14:863-72.
30. Ozen S, Saatci U, Colombani P, et al. Kaposi sarcoma in a paediatric renal transplant recipient. Nephrol Dial Transplant 1996;11:1162-3.
31. Yokois NUJ, Perlman EJ, Colombani P, Wise B, Schwarz KB. Kaposi's sarcoma presenting as a protracted multisystem illness in an adolescent liver transplant recipient. Liver Transplant 1997;5:541-4.
32. Bahat E, Akman S, Karpuzoglu G, et al. Visceral Kaposi's sarcoma with intracranial metastasis: a rare complication of renal transplantation. Pediatr Transplant 2002;6:505-8.
33. Stasko T, Brown MD, Carucci J, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004;30(Suppl):640-648.